Lexeo Therapeutics Price Target Maintained With a $15.00/Share by Leerink Partners
Ratings actions from Benzinga: GMT) Lexeo Therapeutics Is Maintained at Outperform by Leerink PartnersRatings actions from Benzinga
Ratings actions from Benzinga: GMT) Lexeo Therapeutics Is Maintained at Outperform by Leerink PartnersRatings actions from Benzinga